Induction of erythroid differentiation in K562 cells by inhibitors of inosine monophosphate dehydrogenase
- PMID: 2571408
Induction of erythroid differentiation in K562 cells by inhibitors of inosine monophosphate dehydrogenase
Abstract
The effects of three inhibitors of inosine monophosphate (IMP) dehydrogenase on a human erythroleukemic cell line, K562, were studied. Following incubation with these inhibitors, K562 cells underwent differentiation and accumulated hemoglobins. The induction of hemoglobin accumulation was dose dependent; maximum induction was observed at 100, 25, and 3 microM, respectively, for ribavirin, tiazofurin, and mycophenolic acid. The induction was associated with reduction of intracellular GTP content and was blocked by adding guanosine within 24 h after adding inducer. The effective dose for half-maximum induction by ribavirin was 3 times less than that for 50% inhibition of K562 proliferation; however, for tiazofurin and mycophenolic acid, it closely approximated the concentrations which suppressed cellular proliferation. Ribavirin was sequestered preferentially inside the K562 cells, and the induction by ribavirin had a greater than 30-fold increase in hemoglobin. Studies with isoelectric focusing, globin chain analyses, and immunochemical assays indicated that both A gamma and G gamma were detected and that the hemoglobin produced in the ribavirin-treated cells consisted of approximately 60% fetal hemoglobin and its acetylated equivalents. The adult-type alpha globin was found, while no beta globin chains were demonstrated. Thus, accumulation of fetal hemoglobin and production of alpha globin chain in ribavirin-treated cells are different from the pattern of hemoglobins induced by hemin.
Similar articles
-
Effects of the inhibitors of IMP dehydrogenase, tiazofurin and mycophenolic acid, on glycoprotein metabolism.Mol Pharmacol. 1985 Dec;28(6):567-73. Mol Pharmacol. 1985. PMID: 2867464
-
Effects of tiazofurin on globin and proto-oncogene expression in K562 erythroleukemia cells.Cancer Commun. 1989;1(3):191-7. Cancer Commun. 1989. PMID: 2639729
-
Effects of tiazofurin on protooncogene expression during HL-60 cell differentiation.Cancer Res. 1988 Nov 1;48(21):5965-8. Cancer Res. 1988. PMID: 2901907
-
Nucleoside and non-nucleoside IMP dehydrogenase inhibitors as antitumor and antiviral agents.Curr Med Chem. 1999 Jul;6(7):599-614. Curr Med Chem. 1999. PMID: 10390603 Review.
-
Cofactor mimics as selective inhibitors of NAD-dependent inosine monophosphate dehydrogenase (IMPDH)--the major therapeutic target.Curr Med Chem. 2004 Apr;11(7):887-900. doi: 10.2174/0929867043455648. Curr Med Chem. 2004. PMID: 15083807 Review.
Cited by
-
Mycophenolate mofetil. A review of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in renal transplantation.Drugs. 1996 Feb;51(2):278-98. doi: 10.2165/00003495-199651020-00007. Drugs. 1996. PMID: 8808168 Review.
-
Inhibition of T lymphocyte activation in mice heterozygous for loss of the IMPDH II gene.J Clin Invest. 2000 Aug;106(4):599-606. doi: 10.1172/JCI8669. J Clin Invest. 2000. PMID: 10953035 Free PMC article.
-
Overexpression of FAM46A, a Non-canonical Poly(A) Polymerase, Promotes Hemin-Induced Hemoglobinization in K562 Cells.Front Cell Dev Biol. 2020 May 26;8:414. doi: 10.3389/fcell.2020.00414. eCollection 2020. Front Cell Dev Biol. 2020. PMID: 32528962 Free PMC article.
-
Risk factors associated with post-kidney transplant malignancies: an article from the Cancer-Kidney International Network.Clin Kidney J. 2018 Jun;11(3):315-329. doi: 10.1093/ckj/sfx122. Epub 2017 Oct 27. Clin Kidney J. 2018. PMID: 29942495 Free PMC article.
-
Effects of differentiation-inducing agents on purine nucleotide metabolism in an ovarian cancer cell line.J Cancer Res Clin Oncol. 1994;120(12):717-22. doi: 10.1007/BF01194269. J Cancer Res Clin Oncol. 1994. PMID: 7798296 Free PMC article.